Loading clinical trials...
Loading clinical trials...
Illumigene CMV Clinical Trial Protocol
Conditions
Interventions
illumigene CMV assay, illumipro-10
Locations
5
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
University of Utah
Salt Lake City, Utah, United States
The Prince of Wales Hospital
Randwick, New South Wales, Australia
British Columbia Children's Hospital / British Columbia Women's Hospital
Vancouver, British Coloumbia, Canada
Ospedale Sant'Orsola
Via Massarenti 19, Province Of Bologna, Italy
Start Date
August 2, 2017
Primary Completion Date
March 5, 2018
Completion Date
March 5, 2018
Last Updated
January 14, 2019
NCT06439342
NCT07235683
NCT07096453
NCT06453460
NCT05564598
NCT06793124
Lead Sponsor
Meridian Bioscience, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions